The International Study of Asthma and Allergies in Childhood (ISAAC)

哮喘 病因学 医学 过敏 流行病学 疾病 儿科 人口学 家庭医学 环境卫生 免疫学 内科学 社会学
作者
Asher,Weiland
出处
期刊:Clinical & Experimental Allergy [Wiley]
卷期号:28 (s5): 52-66 被引量:550
标识
DOI:10.1046/j.1365-2222.1998.028s5052.x
摘要

Despite considerable research, the aetiology of asthma and allergic disease remains poorly understood. The International Study of Asthma and Allergies In Childhood (ISAAC), was founded to maximize the value of epidemiological research into asthma and allergic disease by establishing a standardized methodology and facilitating international collaboration. It has achieved its specific aims which are to describe the prevalence and severity of asthma, rhinitis and eczema in children living in different centres and to make comparisons within and between countries; to obtain baseline measures for assessment of future trends in the prevalence and severity of these diseases; and to provide a framework for further aetiological research into genetic, lifestyle, environmental and medical care factors affecting these diseases. The ISAAC design comprises three phases. Phase One used simple core written questionnaires for two age groups, and was completed in 156 collaborating centres in 56 countries and a total of 721 601 children participated. In the 13–14 years age group 155 centres from 56 countries participated, of which 99 centres completed a video questionnaire. For the 6–7 years age group there were 91 collaborating centres in 38 countries. ISAAC Phase One has demonstrated a large variation in the prevalence of asthma symptoms in children throughout the world including hitherto unstudied populations. It is likely that environmental factors were responsible for major differences between countries. The results provide a framework for studies between populations in contrasting environ‐ments which are likely to yield new clues about the aetiology of asthma. ISAAC Phase Two will investigate possible aetiological factors, particularly those suggested by the findings of Phase One. ISAAC Phase Three will be a repetition of Phase One in the year 2000 to assess trends in prevalence.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
省略号完成签到,获得积分10
1秒前
丘比特应助学术学习渣子采纳,获得10
3秒前
4秒前
GGgg完成签到,获得积分10
4秒前
沉默是金发布了新的文献求助10
5秒前
5秒前
英姑应助傻子与白痴采纳,获得10
5秒前
今后应助aara采纳,获得10
5秒前
草莓星完成签到,获得积分10
6秒前
WWTWM发布了新的文献求助10
6秒前
马六甲完成签到,获得积分10
6秒前
逸雨涵梦完成签到 ,获得积分10
6秒前
瑞哥哥完成签到 ,获得积分10
7秒前
子车兰完成签到,获得积分10
7秒前
iNk应助Clare采纳,获得10
8秒前
8秒前
OIIII发布了新的文献求助10
9秒前
cca完成签到,获得积分20
9秒前
9秒前
充电宝应助大胆的迎松采纳,获得10
9秒前
9秒前
空海发布了新的文献求助10
10秒前
10秒前
10秒前
11秒前
12秒前
Rain发布了新的文献求助30
12秒前
13秒前
13秒前
宋万里发布了新的文献求助10
14秒前
15秒前
15秒前
月与海完成签到,获得积分10
15秒前
OIIII完成签到,获得积分10
15秒前
沧笙踏歌发布了新的文献求助30
16秒前
16秒前
嘟嘟发布了新的文献求助10
16秒前
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
Electrode Potentials 550
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6960518
求助须知:如何正确求助?哪些是违规求助? 8643289
关于积分的说明 18329842
捐赠科研通 6409080
什么是DOI,文献DOI怎么找? 3085609
关于科研通互助平台的介绍 2133775
邀请新用户注册赠送积分活动 2062172